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Disparities in SARS-CoV-2 Positivity Rates:
Associations with Race and Ethnicity
Harvey W. Kaufman, MD,1 Justin K. Niles, MA,1 and David B. Nash, MD, MBA2
Abstract
Numerous reports indicate that African Americans and Latinos are being affected disproportionately by
coronavirus disease 2019 (COVID-19). Positivity rates have not been analyzed on scale because only 4 states
report race/ethnicity as part of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing. Pre-
vious studies also have had little ability to control for many known risk factors to better identify the effects of
COVID-19 on racial and ethnic communities. Using test results from a large national reference laboratory
database that included patients from all 50 states and the District of Columbia, this study compared positivity
rates for SARS-CoV-2 nucleic acid amplification tests (NAAT) among various race/ethnicity groups by linking
zip code-based race/ethnicity proportions from US Census data. Analysis of 2,331,175 unique patients tested
March-May 2020 demonstrated an increasing trend in SARS-CoV-2 NAAT positivity across Black non-
Hispanic community progressive quintiles (from 7.8% to 17.2%, P < 0.0001) and Hispanic community progres-
sive quintiles (from 8.4% to 15.5%, P < 0.0001) and a decreasing trend across White non-Hispanic community
progressive quintiles (from 17.4% to 7.1%, P < 0.0001). These trends in viral ribonucleic acid positivity re-
mained in stratified analyses and in multivariable models that controlled for known risk factors including sex,
population density, and the states initially hardest hit by COVID-19. These findings indicate that communities
with the highest proportions of Black non-Hispanic and Hispanic populations have the highest SARS-CoV-2
NAAT positivity rates, even after controlling for other risk factors. More efforts are needed to mitigate the
increased impact of COVID-19 on both the African American and Hispanic communities.
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Introduction
Numerous reports support that ethnic minorities arebeing affected disproportionately by SARS-CoV-2 in-
fection and COVID-19 disease.1–6 As of June 24, 2020, there
were nearly 2.4 million confirmed cases of COVID-19 in
the United States and 120,000 COVID-19-related deaths.7
In early June, the reported COVID-19 fatality rate was
nearly 2.5 times higher for African Americans than for the
White non-Hispanic population in the states reporting
race/ethnicity data, with some states showing even larger
disparities.8 These findings are based on data analyses from
the American Public Media Research Lab that indicated
non-Hispanic African Americans accounted for 24% of
COVID-19 deaths, despite comprising only 12% of the US
population.9 The same report noted the mortality rate per
100,000 people was similar among White (22.7), Asian
(24.3), and Latino (24.9) populations.9
As of June 1, 2020, race/ethnicity was included as part
of confirmed positive cases in 47 states and as part of
COVID-19 death reports in 42 states; however, only 4 states
(Delaware, Illinois, Kansas, and Nevada) report race/
ethnicity testing rates,8 making positivity rates based on race
and ethnicity difficult to calculate. Even in states that have
recently reported confirmed cases and deaths by race and
ethnicity (eg, New York), it can be difficult to know the
degree to which these racial divides are affected by large
African American and Hispanic communities in some of
the areas with the most COVID-19 infections (eg, New York
City). Additionally, conflicting outcomes have been re-
ported on the relationship between SARS-CoV-2 nucleic
acid amplification test (NAAT) positivity and race and
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ethnicity, and most prior reports were based on a relatively
small number of individuals.10
Positivity rates reflect positive test results among only
those people who were tested. Therefore, positivity rates are
greatly affected by the amount of testing and the selection of
individuals tested. Laboratory test positivity rates must be
distinguished from infection and disease rates. Infection
rates reflect who is infected in the population; incidence is
defined by the occurrence of new cases whereas prevalence
is defined as the proportion of cases in the population at a
given time. Positivity rates are an additional useful mea-
surement in population disease assessment as they account
for the rapidly evolving number of patients being tested. To
best understand the specific contribution of SARS-CoV-2
NAAT positivity rates, this study examined differences
among US Census-defined race/ethnicity groups using data
from a large national reference laboratory.
Methods
All SARS-CoV-2 ribonucleic acid (RNA) molecular
testing was performed by Quest Diagnostics using 4 dif-
ferent US Food and Drug Administration Emergency Use
Authorized tests; the Quest Diagnostics laboratory-
developed test (Quest SARS-CoV-2 rRT-PCR), the Roche
Diagnostics cobas SARS-CoV-2 test, Hologic Panther Fu-
sion SARS-CoV-2 assay, and Hologic Aptima SARS-CoV-2
test.
Study population
All SARS-CoV-2 NAAT test results performed by Quest
Diagnostics that were stored in the Informatics Data
Warehouse as of June 5, 2020 were retrieved for potential
inclusion in this study. Results were obtained from tests
performed from March 9, 2020 (first day of testing at Quest
Diagnostics) through May 31, 2020. The study population
was limited to 1 result per patient. If any patient SARS-
CoV-2 NAAT test result was positive, that patient was
considered positive and patients with only negative result(s)
were classified as negative. Specimens with equivocal/
inconclusive results were excluded because their status
could not be categorized. Results from patients for whom
the testing laboratory did not provide the residential zip
code – essential to assigning race/ethnicity, income, and pop-
ulation density proportions – also were excluded.
Census estimates by zip code
To analyze race/ethnicity, patient zip code data were
linked to estimated race/ethnicity proportions in each cor-
responding zip code as reported by the 2018 5-year Amer-
ican Community Survey (ACS) on the US Census data
website (the most recent data available).11 The research
team used estimated proportions for single race, Black non-
Hispanic, Hispanic, White non-Hispanic, and Asian non-
Hispanic into categories of the same name. The team
grouped all other race/ethnicities, including multiple race/
ethnicities, into the ‘‘other’’ race/ethnicity categories. To
determine the proportion of testing that likely came from
each race/ethnicity group, the team weighted the result by
the race/ethnicity proportions within that zip code. For ex-
ample, if a specimen came from a community with equal
race/ethnicity proportions for the 5 categories, each would
be assigned a value of 0.2. These values were then summed
in the full analytic data set. To analyze income, mean
household income in the past 12 months (in 2018 inflation-
adjusted dollars) from 2018 ACS 5-Year Estimates was
used.12 Population density data came from the 2010
Census.13 The team analyzed positivity rates by quintiles of
race/ethnicity proportion, population density, and mean in-
come to approximate the association with each of these
factors.
Statistical analyses
The research team controlled for various potentially
confounding factors, such as age, sex, income, and popu-
lation density to better isolate the association of COVID-19
and minority communities, as determined by SARS-CoV-2
NAAT positivity rates. The chi-square test for proportions
and the t test for means were used to analyze differ-
ences between included and excluded patients. Trends in
COVID-19 positivity among race/ethnicity quintiles were
analyzed using the Cochran-Armitage test for trend. All
variables of interest (including statistically insignificant
variables) were included in the multivariable logistic re-
gression model, given their potential as confounders. The
team separately included patient residence in the 5 states
with the highest confirmed COVID-19 rates per capita
(New York, New Jersey, Massachusetts, Rhode Island, and
Connecticut)14 as binary variables in the multivariable
model. Race/ethnicity proportions were included as contin-
uous variables. Data analyses were performed using SAS
Studio 3.6 on SAS 9.4 (SAS Institute Inc., Cary, NC, USA).
This Quest Diagnostics Health Trends study was deemed
exempt by the Western Institutional Review Board (Puyallup,
Washington).
Results
The potential cohort included 3,134,778 SARS-CoV-2
molecular specimens from 2,935,158 unique patients
representing all 50 states and the District of Columbia. Pa-
tients without valid residential zip code data (n = 600,472)
were excluded followed by those with equivocal/inconclusive
results (n = 3511). The final analytic cohort (N = 2,331,175)
constituted 79.4% of potential patients for whom definitive
SARS-CoV-2 NAAT were obtained. Included patients were
younger, on average, than excluded patients (45.8 standard
deviation [SD] 18.5 vs. 46.3 SD 18.1, P < 0.0001) and more
likely to be female (56.5%, 95% confidence interval [CI]
56.5–56.5%, vs 55.7%, 95% CI 55.6–55.8%, P < 0.0001).
The SARS-CoV-2 NAAT positivity rate was higher for the
included population than the excluded population (11.6%,
95% CI 11.6–11.7%, vs 11.4%, 95% CI 11.3–11.5%,
P < 0.0001). The study population was 12.4% Black non-
Hispanic, 22.1% Hispanic, 56.1% White non-Hispanic, 5.9%
Asian non-Hispanic, and 3.5% ‘‘other’’ race/ethnicities.
These proportions are very close to American Community
Survey 2018 estimates for the national population (12.3%
Black non-Hispanic, 18.3% Hispanic, 60.2% White non-
Hispanic, 5.6% Asian non-Hispanic, and 3.6% for all other
ethnicities).15
There was a statistically significant increasing trend in
SARS-CoV-2 NAAT positivity for Black non-Hispanic
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quintiles (from 7.8% to 17.2%, P < 0.0001), Hispanic quin-
tiles (from 8.4% to 15.5%, P < 0.0001), and Asian non-
Hispanic quintiles (from 9.6% to 13.4%, P < 0.0001) during
the time period of March 9 through May 31, 2020. There was
a statistically significant decreasing trend in SARS-CoV-2
NAAT positivity for White non-Hispanic quintiles (from
17.4% to 7.1%, P < 0.0001) and ‘‘other’’ race/ethnicity
quintiles (from 13.2% to 8.9%, P < 0.0001) (Figure 1).
Progressive quintiles of population density also demonstra-
ted a statistically significant increasing trend (P < 0.0001)
in SARS-CoV-2 NAAT positivity rates (quintile 1, 6.8%;
quintile 2, 8.4%; quintile 3, 10.8%; quintile 4, 12.3%;
quintile 5, 19.8%). Positivity rates were analyzed for race/
ethnicity quintiles in the most densely populated areas
(quintile 5 of population density) and the least densely
populated areas (quintile 1 of population density) (Figure 2).
Statistically significant increasing trends in positivity for
the Black non-Hispanic and Hispanic populations were
demonstrated in both the most densely populated areas
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FIG. 1. COVID-19 positivity by race/ethnicity community quintiles. Quintiles were derived from analysis of race/
ethnicity proportions as estimated by the US Census Bureau (2018 American Community Survey 5-Year Estimates).
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FIG. 2. COVID-19 positivity by race/ethnicity community quintiles in the most and least densely populated areas.
Quintiles were derived from analysis of race/ethnicity proportions as estimated for each zip code by the US Census Bureau
(2018 American Community Survey 5-Year Estimates). Population density quintiles were derived from analysis of each zip
code by the US Census Bureau (2010 Census). Cochran-Armitage test for trend, P < 0.0001 for all groups except Asian non-
Hispanic in least densely populated areas (not significant).
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(P < 0.0001 for all). Statistically significant decreasing
trends in positivity for the White non-Hispanic population
and the ‘‘other’’ race/ethnicity populations were demonstra-
ted in the most and least densely populated areas (P < 0.0001
for both). Statistically significant decreasing trends in pos-
itivity for the Asian non-Hispanic population were demon-
strated in the most densely populated areas (P < 0.0001) but
there was no significant trend in the least densely populated
areas.
Progressive quintiles of mean income demonstrated a small
but statistically significant decreasing trend (P < 0.0001) in
SARS-CoV-2 NAAT positivity rates (quintile 1, 12.7%;
quintile 2, 10.9%; quintile 3, 12.1%; quintile 4, 11.5%; quin-
tile 5, 11.0%). Positivity rates for race/ethnicity quintiles in
the highest income quintile and lowest income quintile were
analyzed (Figure 3). Statistically significant increasing trends
in positivity for the Black non-Hispanic, Hispanic, and Asian
non-Hispanic populations were demonstrated in both the
highest and lowest income areas (P < 0.0001 for all). Statis-
tically significant decreasing trends in positivity for the White
non-Hispanic population and the ‘‘other’’ race/ethnicity
populations were demonstrated in both the highest and lowest
income areas (P < 0.0001 for all). In virtually every case, the
race/ethnicity quintile differences were considerably larger
in the lowest income quintile than they were in the highest
income quintile.
The increases in positivity associated with increases in
proportions of Black non-Hispanic and Hispanic populations
also are demonstrated in multivariable models (Table 1).
The model indicates significant increased risk of SARS-
CoV-2 NAAT positivity for males, and patients from indi-
vidual states (New York, New Jersey, Connecticut, and
Massachusetts). There was a stepwise relationship between
progressive population density quintiles and SARS-CoV-2
NAAT positivity and a smaller, but also stepwise relation-
ship between progressive income quintiles and SARS-CoV-
2 NAAT positivity. The association between SARS-CoV-2
NAAT positivity and increases in proportion of the Asian
non-Hispanic population changed from being strongly pre-
dictive in the unadjusted model (unadjusted odds ratio 4.61,
95% CI 4.40–4.83) to slightly protective in the adjusted
model (adjusted odds ratio 0.94, 95% CI 0.89–0.99).
Discussion
These findings on a national basis suggest that COVID-19
has disproportionately affected Black non-Hispanic com-
munities, consistent in scope with previous analyses of
confirmed positive cases and mortality.1–6 The results indi-
cate that Hispanic communities have been disproportion-
ately affected as well, a subject that has not been thoroughly
researched previously. In both populations, these results are
indicated even in a multivariable model controlling for
known risk factors such as sex, the hardest hit individual
states, and population density.
Study data suggest that Black non-Hispanic and Hispanic
communities are representative among all patients tested for
SARS-CoV-2 RNA. The reasons for increased SARS-CoV-
2 positivity rates in Black non-Hispanic and Hispanic
communities tested are likely as complex as the communi-
ties themselves; however, population health experts have
proposed several situations that could be causing these
disparities. Ethnic minorities are overrepresented in essen-
tial jobs in industries including transportation, government,
health care, and food supply services, which may increase
their chances of being infected while at work.16 Previous
research also has shown higher rates of diseases such as
diabetes, heart disease,17 and obesity18 in African Ameri-
cans, all of which have been linked to COVID-19 mortali-
ty,19 although the impact of these conditions on infection
FIG. 3. COVID-19 positivity by race/ethnicity community quintiles in the highest and lowest income areas. Quintiles
were derived from analysis of race/ethnicity proportions and mean income as estimated for each zip code by the US Census
Bureau (2018 American Community Survey 5-Year Estimates). Cochran-Armitage test for trend, P < 0.0001 for all groups.
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rates has not yet been fully explored.20–22 In contrast,
studies demonstrated that among people ages 65 years and
older, African American and Latino compared to White
people have lower mortality from influenza and pneumonia
as causes of death.17,23
Public health experts also have suggested that many risk
factors for COVID-19 are connected in part to socioeco-
nomic status, collectively referred to as social determinants
of health, including reliance on public transportation for
those who cannot afford a car, living in densely populated
areas, having jobs without paid sick leave, disparities in
access to quality health care, and living in smaller multi-
family (or multigenerational) homes that make social dis-
tancing inconvenient or even impossible.24 The cumulative
impact of social inequities from an early age may influence
racial and ethnic disparities in both clinical and subclini-
cal health conditions.25 Although the research team agrees
with these factors in theory, data presented in this study
demonstrated higher rates of SARS-CoV-2 positivity in
higher income communities, after controlling for other
factors in multivariable models. This was unexpected, es-
pecially given the small but significant association of higher
income quintiles with lower SARS-CoV-2 positivity rates in
unadjusted analysis. One possible explanation is that a dis-
proportionate number of employed health care workers are
being tested for SARS-CoV-2. While there is a wide range
of incomes among health care workers, some, notably
physicians, have higher incomes and high exposure fre-
quency to infected patients. Moreover, COVID-19 positivity
rate disparities by race/ethnicity (particularly for the Black
non-Hispanic community) remained even within the highest
income communities, suggesting that lower income may not
play as large a role as previously assumed. It is also im-
portant to keep in mind that the income variable used was
based on the mean income for a patient’s zip code. The
relationship between patient income and COVID-19 posi-
tivity within zip codes, unfortunately, could not be analyzed
for this study. Inclusion of these additional covariates may
have yielded different results.
Other results from the multivariable models were inter-
esting as well. To the research team’s knowledge, this is the
first study to examine SARS-CoV-2 molecular positivity
rates by population density quintiles. Unsurprisingly, higher
population density rates were associated with higher
Table 1. Factors Associated with COVID-19 Positivity
Factors
Unadjusted odds ratio
(95% Wald confidence limits)
Adjusted odds ratio
(95% Wald confidence limits)
Race/ethnicity proportions
Black non-Hispanic 5.34 (5.24–5.45) 4.60 (4.48–4.72)
Hispanic 3.10 (3.05–3.15) 3.06 (2.99–3.13)
Asian non-Hispanic 4.61 (4.40–4.83) 0.94 (0.89–0.99)
‘‘Other’’ race/ethnicity 1.00 (1.00–1.00) 1.18 (1.07–1.30)
White non-Hispanic reference reference
Age 0.997 (0.996–0.997) 0.998 (0.998–0.998)
Sex
Male 1.22 (1.21–1.23) 1.23 (1.22–1.24)
Female reference reference
Population Density
Quintile 5 (highest density) 3.37 (3.32–3.41) 1.61 (1.59–1.64)
Quintile 4 1.91 (1.89–1.94) 1.35 (1.33–1.38)
Quintile 3 1.64 (1.62–1.67) 1.21 (1.19–1.23)
Quintile 2 1.25 (1.23–1.27) 1.01 (1.00–1.03)
Quintile 1 (lowest density) reference reference
Mean Income
Quintile 5 (highest income) 0.85 (0.84–0.86) 1.23 (1.21–1.25)
Quintile 4 0.89 (0.88–0.90) 1.23 (1.21–1.24)
Quintile 3 0.94 (0.93–0.95) 1.16 (1.14–1.18)
Quintile 2 0.84 (0.83–0.85) 1.07 (1.06–1.09)
Quintile 1 (lowest income) reference reference
Patient State
New York 2.81 (2.77–2.84) 2.45 (2.41–2.48)
New Jersey 3.02 (2.97–3.06) 2.63 (2.59–2.68)
Connecticut 1.72 (1.68–1.75) 1.79 (1.75–1.83)
Massachusetts 1.83 (1.80–1.85) 2.02 (1.99–2.05)
Rhode Island 0.83 (0.75–0.91) 1.01 (0.92–1.11)
All Others reference reference
Multivariable model included 2,261,456 of 2,331,175 (97.1%) of the study population with no missing data for any variables included in
the model. Odds ratios for race/ethnicity proportions should be interpreted using the following example; a 1% increase in the Black non-
Hispanic proportion within a zip code corresponds to the odds of testing positive for SARS-CoV-2 increasing by a factor of 4.6.
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positivity rates, but the strength and stepwise nature of this
association were remarkable. Although more females than
males are tested, male patients were more likely to test pos-
itive than female patients, consistent with previous literature
showing that male patients are associated with increased
SARS-CoV-2 NAAT positivity,26 increased hospitalization
rates,26 and mortality.27 Four of the 5 states with the highest
per capita confirmed positivity rates nationally also were
strongly associated with positivity in this study, though res-
idence in Rhode Island was not significantly associated with
positivity in the adjusted multivariable model.
Limitations and strengths
A clear limitation of this study is that there were no direct
patient ethnicity data, and the estimates are based on aggre-
gate US Census race/ethnicity proportions by zip code. Other
related limitations include that patients may not be tested at
the same race/ethnicity mix within each zip code, some pa-
tients may reside in one zip code but became infected
somewhere else, and that, historically, hospitals have been
less likely to provide patient zip code information than other
facility types. Further, testing was based on specimens sub-
mitted to Quest Diagnostics only; other testing sites and
laboratories may have tested a different proportion of patients
within each zip code. However, analysis of test share indi-
cated the population being tested for COVID-19 by Quest
Diagnostics appears to largely reflect the overall United
States regarding race/ethnicity proportions, at least when
analyzed by zip code. COVID-19 testing is typically not
random. People with symptoms or high exposure risk (eg,
health care workers) are theoretically more likely to be tested.
Yet some random testing is occurring as well, such as in-
stances of preoperation screening. The mix of these factors,
and how they have changed over the time interval evaluated
in this study, is unknown. Further, these results reflect the
early months of COVID-19 in the United States. Data from
later time periods may show different associations. Strengths
included the large analytic cohort, which included patients
from all 50 states and the District of Columbia, and the
number of factors controlled for in multivariable models,
which allowed for better isolation of the impact COVID-19
has had on racial and ethnic minority communities.
Conclusions
Communities with the highest proportions of Black non--
Hispanic and Hispanic populations have the highest SARS-
Cov-2 molecular positivity rates, falling in line with previous
findings on confirmed COVID-19 cases and mortality.
However, this study demonstrated that these higher rates exist
even after controlling for many other potentially significant
risk factors, including population density and income. Al-
though, clearly, more epidemiological research is needed, the
strength of these associations suggests that more efforts ur-
gently need to be made to help mitigate the increased impact
of COVID-19 and, more broadly, the health disparities af-
fecting both African Americans and Hispanics.28
Author Contributions
Drs. Kaufman and Nash and Mr. Niles all contributed to
writing, reviewing, and revising the manuscript for intel-
lectual and technical content. Dr. Kaufman and Mr. Niles
contributed to study design. Mr. Niles performed all data
analyses.
Author Disclosure Statement
The authors declare that there are no conflicts of interest.
Funding Information
Quest Diagnostics provided support in the form of sal-
aries for Dr. Kaufman and Mr. Niles but did not have any
additional role in the study design; collection, analysis, or
interpretation of data; writing of the manuscript; or decision
to publish.
References
1. Khunti K, Singh AK, Pareek M, Hanif W. Is ethnicity
linked to incidence or outcomes of covid-19? BMJ 2020;
369:m1548.
2. Hastie CE, Mackay DF, Ho F, et al. Vitamin D concen-
trations and COVID-19 infection in UK biobank. Diabetes
Metab Syndr 2020;14:561–565
3. Bhala N, Curry G, Martineau AR, Agyemang C, Bhopal R.
Sharpening the global focus on ethnicity and race in the tie
of COVID-19. Lancet 2020;395:1673–1676.
4. US Centers for Disease Control and Prevention Provisional
death counts for coronavirus disease (COVID-19): weekly
state-specific data updates by select demographic and geo-
graphic characteristics. 2020. https://www.cdc.gov/nchs/
nvss/vsrr/covid_weekly/ Accessed June 4, 2020.
5. Chicago Department of Public Health. Latest data. 2020.
https://www1.nyc.gov/site/doh/covid/covid-19-data.page
Accessed June 24, 2020.
6. NYC Health. COVID-19: data. https://www1.nyc.gov/site/
doh/covid/covid-19-data.page Accessed June 24, 2020.
7. Johns Hopkins University and Medicine. COVID19 Dash-
board by the Center for Systems Science and Engineering
at JHU. https://coronavirus.jhu.edu/map.html Accessed
June 24, 2020.
8. Cuthbertson A. Coronavirus tracked: how Covid-19 deaths
in the US compare by race and ethnicity. https://www
.independent.co.uk/news/world/americas/coronavirus-deaths-
us-race-black-white-asian-latino-racism-a9544401.html Ac-
cessed June 3, 2020.
9. American Public Media Research Lab. The color of cor-
onavirus: COVID-19 deaths by race and ethnicity in the
U.S. May 27, 2010. https://www.apmresearchlab.org/covid/
deaths-by-race Accessed June 3, 2020.
10. Pan D, Sze S, Minon-Hispanicas JS, et al. The impact of
ethnicity on clinical outcomes in COVID-19: a systematic
review. EClinicalMedicine 2020;23:100404.
11. U.S. Census Bureau; American Community Survey, 2018
American Community Survey 5-Year Estimates, Table
B03002; generated by Justin Niles; using data.census.gov.
https://data.census.gov/cedsi/ Accessed June 1, 2020.
12. U.S. Census Bureau; American Community Survey, 2018
American Community Survey 5-Year Estimates, Table
S1902; generated by Justin Niles; using data.census.gov.
https://data.census.gov/cedsi/ Accessed June 10, 2020.




SARS-COV-2 POSITIVITY: RACE AND ETHNIC DISPARITIES 25
14. The New York Times. Coronavirus in the U.S.: Latest map
and case count. https://www.nytimes.com/interactive/2020/
us/coronavirus-us-cases.html#states Accessed June 2, 2020.
15. U.S. Census Bureau; American Community Survey, 2018
American Community Survey 1-Year Estimates, Table
DP05; generated by Justin Niles; using data.census.gov.
https://data.census.gov/cedsi/ Accessed June 1, 2020.
16. Johns Hopkins University and Medicine. Racial data trans-
parency. https://coronavirus.jhu.edu/map.html Accessed
June 1, 2020.
17. Cunningham TJ, Croft JB, Liu Y, et al. Vital signs: racial
disparities in age-specific mortality among Blacks or
African-Americans—United States, 1999–2015. MMWR
Morb Mortal Wkly Rep 2017;66:444–456.
18. U.S. Department of Health and Human Services, Office of
Minority Health. Obesity and African-Americans. https://
www.minorityhealth.hhs.gov/omh/browse.aspx?lvl=4&lvlid=
25 Accessed June 15, 2020.
19. Zhou F, Yu T, Du R, et al. Clinical course and risk
factors for mortality of adult inpatients with COVID-19
in Wuhan, China: a retrospective cohort study. Lancet
2020;395:1054–1062.
20. Shi S, Qin M, Shen B, et al. Association of cardiac injury
with mortality in hospitalized patients with COVID19 in
Wuhan, China. JAMA Cardiol 2020;5:802–810.
21. Bonow RO, Fonarow GC, O’Gara PT, Yancy CW. Asso-
ciation of coronavirus disease 2019 (COVID-19) with myo-
cardial injury and mortality. JAMA Cardiol 2020;5:751–753.
22. Grasselli G, Zangrillo A, Zanella A, et al; COVID-19
Lombardy ICU Network. Baseline characteristics and
outcomes of 1591 patients infected with SARS-CoV-2
admitted to ICUs of the Lombardy region, Italy. JAMA
2020;323:1574–1581.
23. Dominguez K, Penman-Aguilar A, Chang MH, et al.
Centers for Disease Control and Prevention (CDC). Vital
signs: leading causes of death, prevalence of diseases and
risk factors, and use of health services among Hispanics in
the United States—2009–2013. MMWR Morb Mortal
Wkly Rep.2015;64:469–478.
24. Centers for Disease Control and Prevention. COVID-19 in
racial and ethnic minority groups. https://www.cdc.gov/
coronavirus/2019-ncov/need-extra-precautions/racial-ethnic-
minorities.html#10 Accessed June 4, 2020.
25. Geronimus AT, Hicken M, Keene D, Bound J. ‘‘Weath-
ering’’ and age patterns of allostatic load scores among
blacks and whites in the United States. Am J Public Health
2005;96:826–833.




27. Gebhard C, Regitz-Zagrosek V, Neuhasuer HK, Morgan R,
Klein SL. Impact of sex and gender on COVID-19 out-
comes in Europe. Biol Sex Differ 2020;11:29.
28. Yancy CW. COVID-19 and African-Americans. JAMA
2020;323:1891–1892.
Address correspondence to:






26 KAUFMAN ET AL.
This article has been cited by:
1. Jill B. Hamilton, Nakia C. Best, Tara A. Barney, Valarie C. Worthy, Nichole R. Phillips. 2021. Using Spirituality to Cope with
COVID-19: the Experiences of African American Breast Cancer Survivors. Journal of Cancer Education 7. . [Crossref]
2. Omolola E. Adepoju, Chinedum O. Ojinnaka. County-Level Determinants of COVID-19 Testing and Cases: Are there Racial/
Ethnic Disparities in Texas?. Population Health Management, ahead of print. [Abstract] [Full Text] [PDF] [PDF Plus]
